Hepcinelt LP In Stock
Hepatitis Medicine

Hepcinelt LP

Hepcinat-LP is a combination antiviral medicine used in the treatment of chronic Hepatitis C virus (HCV) infection.
It helps to stop the virus from multiplying inside the body and improves liver health over time. This medicine has shown high cure rates for various genotypes of Hepatitis C.

Product Details

Product Information

  • Brand Name: Hepcinat-LP
  • Generic Composition: Ledipasvir 90 mg + Sofosbuvir 400 mg
  • Manufacturer: Natco Pharma Ltd.
  • Form: Film-Coated Tablet
  • Packaging: 28 Tablets / Bottle ---

Key Benefits

  • Used in the treatment of chronic Hepatitis C virus (HCV) infection in appropriate patients.
  • Helps suppress the replication of the Hepatitis C virus and supports viral clearance during treatment.
  • Can help reduce the risk of long-term liver complications associated with chronic Hepatitis C when effective treatment is achieved.
  • Provides an oral treatment option for eligible patients.
  • Treatment duration and suitability depend on the patient's HCV genotype, liver condition, previous treatment history, and other clinical factors. ---

How to Use

  • Take one tablet once daily, with or without food, or exactly as prescribed by your healthcare provider.
  • Swallow the tablet whole with water. Do not crush or chew unless specifically advised.
  • Take the medicine at approximately the same time each day.
  • Complete the full prescribed treatment course, even if you feel better.
  • Do not stop treatment or change the dose without consulting your doctor. ---

Safety Information

  • Inform your doctor about all medicines and supplements you are taking, especially medicines containing amiodarone, certain anticonvulsants, rifampicin, or St. John's wort, as some medicines can interact with this treatment.
  • If you take an acid-reducing medicine such as an antacid or proton-pump inhibitor, consult your healthcare provider about appropriate timing.
  • Tell your doctor if you have liver disease, kidney disease, Hepatitis B infection, or a history of liver problems.
  • Patients with Hepatitis B should be appropriately evaluated because Hepatitis B reactivation can occur during treatment with direct-acting antivirals.
  • Pregnancy and breastfeeding considerations should be discussed with your healthcare provider, particularly when treatment is being used in combination with other medicines.
  • Avoid self-medication and unnecessary medicines that may affect liver function. ---

Possible Side Effects

    Some patients may experience:
  • Headache
  • Fatigue or weakness
  • Nausea
  • Diarrhea
  • Dizziness
  • Insomnia or difficulty sleeping Most side effects are generally manageable, but consult your healthcare provider if symptoms are severe, persistent, or unusual. ---

Storage & Packaging

  • Store at room temperature according to the manufacturer's instructions.
  • Keep away from excessive heat, moisture, and direct sunlight.
  • Keep the tablets in their original, tightly closed container.
  • Supplied in a sealed bottle containing 28 film-coated tablets.
  • Keep out of reach of children. ---

Disclaimer

Hepcinat-LP is a prescription medicine and should be used only under the supervision of a qualified healthcare professional.
The appropriate treatment duration and regimen vary depending on the patient's HCV infection, liver condition, previous treatment, and other medical factors.
The information provided here is for educational and informational purposes only and should not replace professional medical advice.